Why a rare endocrine disorder can masquerade as attention deficit — and why adult-onset focus problems deserve a closer look.
Harold Robert Meyer | The ADD Resource Center
haroldmeyer@addrc.org http://www.addrc.org/
Reviewed 05/10/2026 – Published 05/10/2026
Listen to understand, not just to respond
There is no established epidemiological correlation between Cushing’s syndrome and ADHD — people with one condition are not more likely to develop the other. But the two share a striking symptomatic overlap that creates real diagnostic risk. Chronic cortisol excess produces inattention, distractibility, working memory problems, and mental “blanking” that look indistinguishable from inattentive-presentation ADHD. For adults experiencing new or worsening focus problems — particularly alongside physical changes like central weight gain, hypertension, or mood shifts — ruling out endocrine causes before starting stimulant medication is a step that can change everything.
If you are an adult presenting with attention problems for the first time in your 30s, 40s, or 50s, the default clinical path often leads to an ADHD evaluation, a self-report screener, and a prescription. That path works well when the diagnosis is correct. When it isn’t — when the true driver is a pituitary or adrenal tumor producing excess cortisol — stimulant medication may provide modest symptomatic relief while the underlying disease progresses untreated. Cushing’s syndrome, left unaddressed, carries serious cardiovascular, metabolic, and neurological consequences. The case for accurate differential diagnosis is not academic.
For parents and clinicians, the issue is equally consequential in pediatric cases, where Cushing’s is rarer but does occur — particularly in certain genetic conditions — and where attention and behavioral symptoms may be the earliest presenting complaint.
Attention problems are a defining feature of Cushing’s syndrome, not an incidental one. Research has documented that roughly two-thirds of Cushing’s patients report impaired concentration, mind-wandering during reading or conversation, shortened attention span, and difficulty with reasoning and comprehension (Pivonello et al., 2015). Many describe episodes of rapid, scattered thinking alternating with moments when the mind “goes blank” — a pattern clinicians regularly hear from adults with inattentive ADHD.
Objective testing confirms the subjective complaints. In one clinical sample, adults with Cushing’s syndrome showed significant deficits in sustained attention and visual-spatial functioning, with attention and irritability being the most common patient complaints (Andela et al., 2020). Earlier work similarly identified attention deficits, slowed processing speed, and reduced verbal fluency in patients with active disease (Forget et al., 2000).
Cognitive deficits often persist after the endocrine disease is treated. This is perhaps the most clinically important finding. A study of 55 patients in long-term remission — median 13 years post-treatment — found they still demonstrated impaired attention, working memory, verbal fluency, spatial orienting, and reading speed compared to matched controls, independent of mood or fatigue (Ragnarsson et al., 2012). The authors concluded the pattern suggests broad brain involvement rather than localized damage. Translation: cortisol-driven attention problems can outlast the cortisol itself.
Misdiagnosis runs in both directions. Cushing’s patients frequently cycle through multiple providers before receiving an accurate diagnosis, and are sometimes dismissed by clinicians who attribute symptoms to depression, anxiety, or unspecified cognitive complaints (Andela et al., 2020). The reverse error — treating endocrine-driven attention problems as primary ADHD — is plausible but under-documented, precisely because it tends not to get caught.
“An adult who develops focus problems for the first time in midlife deserves a broader workup than a self-report questionnaire. The symptoms may be the same; the cause — and the treatment — may not be.” — Harold Meyer, The ADD Resource Center
The case for endocrine evaluation grows stronger when attention complaints arrive alongside:
Any clustering of these signs with attention symptoms should prompt a conversation about cortisol testing — typically 24-hour urinary free cortisol, late-night salivary cortisol, or a dexamethasone suppression test — before ADHD treatment is initiated.
This article does not suggest that your attention problems are likely due to Cushing’s. Cushing’s syndrome is rare — affecting roughly 40 to 70 people per million — while ADHD affects approximately 4% of U.S. adults. Statistically, ADHD remains the far more likely explanation for attention difficulties, and the vast majority of adults seeking evaluation will receive an appropriate ADHD diagnosis.
The point is narrower and more practical: when attention symptoms appear in atypical patterns or alongside unexplained physical changes, a thorough differential matters. Cushing’s is one of several medical conditions — along with thyroid disorders, sleep apnea, and others — that a careful clinician should consider before settling on ADHD as the diagnosis.
If you are seeking an evaluation for adult attention problems, bring a complete picture to the appointment: your full medical history, any recent physical changes, a timeline of when symptoms began, and any family history of endocrine conditions. Ask your clinician explicitly what medical conditions they are ruling out as part of the assessment. A good evaluation is more than a questionnaire, and a good clinician will welcome the question.
If you have been diagnosed with Cushing’s syndrome and are experiencing persistent attention problems — whether during active disease or long after remission — know that the research supports you. These difficulties are real, organic, and documented. They deserve the same accommodations and cognitive support strategies that benefit adults with ADHD, even when the underlying cause is different.
Andela, C. D., van der Werff, S. J. A., Pannekoek, J. N., van den Berg, S. M., Meijer, O. C., van Buchem, M. A., Rombouts, S. A. R. B., van der Mast, R. C., Romijn, J. A., Tiemensma, J., Biermasz, N. R., van der Wee, N. J. A., & Pereira, A. M. (2020). Neuropsychological and emotional functioning in patients with Cushing’s syndrome. Behavioural Neurology, 2020, Article 9162158. https://doi.org/10.1155/2020/9162158
Forget, H., Lacroix, A., Somma, M., & Cohen, H. (2000). Cognitive decline in patients with Cushing’s syndrome. Journal of the International Neuropsychological Society, 6(1), 20–29. https://doi.org/10.1017/S1355617700611037
Pivonello, R., Simeoli, C., De Martino, M. C., Cozzolino, A., De Leo, M., Iacuaniello, D., Pivonello, C., Negri, M., Pellecchia, M. T., Iasevoli, F., & Colao, A. (2015). Neuropsychiatric disorders in Cushing’s syndrome. Frontiers in Neuroscience, 9, Article 129. https://doi.org/10.3389/fnins.2015.00129
Ragnarsson, O., Berglund, P., Eder, D. N., & Johannsson, G. (2012). Long-term cognitive impairments and attentional deficits in patients with Cushing’s disease and cortisol-producing adrenal adenoma in remission. Journal of Clinical Endocrinology & Metabolism, 97(9), E1640–E1648. https://doi.org/10.1210/jc.2012-1945
Starkman, M. N. (2013). Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration. Endocrinology and Metabolism Clinics of North America, 42(3), 477–488. https://doi.org/10.1016/j.ecl.2013.05.010
Starkman, M. N., Schteingart, D. E., & Schork, M. A. (1981). Depressed mood and other psychiatric manifestations of Cushing’s syndrome: Relationships to hormone levels. Psychosomatic Medicine, 43(1), 3–18. https://doi.org/10.1097/00006842-198102000-00002
About The Author
Harold Meyer is the founder of The A.D.D. Resource Center, established in 1993. For over 30 years, he has been a leading advocate, coach, and educator in the ADHD space, translating the real experiences of individuals with ADHD into practical guidance for families, professionals, and institutions. He co-founded CHADD of New York, served as CHADD’s national treasurer, and was president of the Institute for the Advancement of ADHD Coaching. An author and international speaker, he has presented at the American Psychiatric Association and CHADD national conferences. haroldmeyer@addrc.org
Contact
info@addrc.org (mailto:info@addrc.org) • +1 (646) 205-8080
127 West 83rd St., Unit 133, Planetarium Station, New York, NY 10024-0840 USA
X | LinkedIn | Substack | ADHD Research and Innovation
Join Our Community
Subscribe to the ADD Resource Center newsletter for the latest resources and insights → Click here.
Disclaimers
Content is for educational purposes only and is not a substitute for professional advice. We strive for accuracy, though errors can occur. Some material may be AI-generated; please verify independently. Rejection Sensitive Dysphoria (RSD) is recognized by many providers but is not in the DSM.
In the USA and Canada, call or text 988 anytime for free mental health and suicide prevention support.
Privacy & Legal
Under GDPR and CCPA, you may request access to, correction of, or deletion of your personal data at info@addrc.org.© 2026 Harold R. Meyer / ADD Resource Center. All rights reserved. Content may be shared only in complete, unaltered form with attribution. Reproduction or commercial use requires written permission (addrc@mail.com).
Couples affected by ADHD already face higher rates of conflict and relationship breakdown, and emotion…
The first medication talk is rarely the last — it sets the template your child…
The habit of owning every failure while crediting every success to luck is not an…
For a person with ADHD, the greatest threat to close relationships is rarely conflict —…
When ADHD and psychosis are confused, the cost is high. A person with emerging psychosis…
